In a significant move within the North African healthcare landscape, the private equity firm Adenia Partners has signed definitive agreements to acquire a majority interest in Parkville Pharmaceuticals. The stake is being acquired from Admaius Capital Partners, with the transaction involving a partnership with Parkville’s original leadership, including Chairman Sherif Bassiouny and CEO Mahmoud Farrag.
Headquartered in Cairo, Parkville Pharmaceuticals established itself as a resilient player in Egypt’s diversified healthcare market. While the financial specifics of the deal remain confidential, the transaction is currently progressing through customary regulatory approvals and closing conditions.
A Diversified Healthcare Portfolio
Since its founding in 2008, Parkville has expanded far beyond traditional medicine. The company operates across three high-growth verticals:
- Pharmaceuticals: Development and distribution of therapeutic lines.
- Cosmeceuticals: Specialized skincare, haircare, and personal care products (including deodorants).
- Nutraceuticals: Wellness and nutritional supplement products.
This multi-sector approach has allowed Parkville to capture a broad consumer base, ranging from clinical patients to retail wellness shoppers.
This acquisition is a landmark for Adenia Partners, marking their first investment in Egypt. The move signals a strong belief in the country’s long-term economic fundamentals and its ability to produce regional market leaders.
Stéphane Bacquaert, Managing Partner of Adenia Partners, highlighted the scalability of the business:
We are delighted our first acquisition in Egypt is into one of the region’s fastest growing businesses. We see tremendous potential in Parkville’s mission to expand access to affordable, high-quality health and personal care products.
Heba Hakky, Principal at Adenia, added that the investment reflects a conviction in the strength of local champions and the next phase of growth for the Egyptian pharmaceutical sector.
Under the leadership of Dr. Mahmoud Farrag, Parkville has undergone a significant transformation over the last two years. The partnership with Adenia is intended to fuel a more aggressive expansion strategy:
- Product Diversification: Expanding the current offering across health and personal care categories.
- Digital & Commercial Strengthening: Enhancing the company’s ability to reach consumers through modern retail and digital channels.
- Regional Growth: Using Egypt as a springboard to scale operations across the Middle East and Africa (MEA).
Dr. Farrag noted that the ambition is now to position Parkville as a “Middle East and Africa champion,” delivering sustainable value for investors while maintaining an empowering environment for its workforce.
The transaction also marks a successful outcome for Admaius Capital Partners, who partnered with Parkville during a critical two-year period of value creation. The sale demonstrates a healthy “deal flow” within the Egyptian private equity space, showing that international firms can successfully scale and exit high-quality local assets.
